Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humpuss Maritim Internasional Tbk. (HUMI) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

Humpuss Maritim Internasional Tbk.Trade
Hetzer Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Humpuss Maritim Internasional Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Humpuss Maritim Internasional Tbk. trades at Rp147 (market cap 2.64T, 18.01M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume). The key difference: Humpuss Maritim Internasional Tbk. is far larger — about 23.1× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 18.01M). Which is the better fit depends on your goals.

HUMIMEDS
Market Cap
2.64T114.06B
Volume
18.01M23.06M
Lot
180.11K230.55K
Turnover
2.63B1.68B
Average Price
145.9472.75
Value
2.63B1.68B
Indicative Equilibrium Price
14772
Indicative Equilibrium Volume
14.79K1.56K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HUMI
View details
MEDS
View details

About Humpuss Maritim Internasional Tbk.

PT Humpuss Maritim Internasional Tbk. (the Company) is a limited liability company incorporated under the laws of the Republic of Indonesia by virtue of Notarial Deed No. 21 dated September 29, 2016 of Martina, S.H., Notary in Jakarta. The Company change its name from PT MISI Hutama Internasional to PT Humpuss Maritim Internasional. The Company has started its commercial operation since December 2016. Parent entity ofthe Company is PT Humpuss Transportasi Kimia and ultimate parent of the Company is PT Humpuss Intermoda Transportasi Tbk. The Company’s controlling party is H. Hutomo Mandala Putra, SH.

Read more on HUMI

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS